ES2130185T3 - Fragmento de adn codante para un factor de inhibicion de la proliferacion de celulas tumorales. - Google Patents

Fragmento de adn codante para un factor de inhibicion de la proliferacion de celulas tumorales.

Info

Publication number
ES2130185T3
ES2130185T3 ES92924873T ES92924873T ES2130185T3 ES 2130185 T3 ES2130185 T3 ES 2130185T3 ES 92924873 T ES92924873 T ES 92924873T ES 92924873 T ES92924873 T ES 92924873T ES 2130185 T3 ES2130185 T3 ES 2130185T3
Authority
ES
Spain
Prior art keywords
inhibition factor
cell proliferation
tumor cell
dna fragment
codant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92924873T
Other languages
English (en)
Inventor
Toshi Komurasaki
Hitoshi Toyoda
Makoto Yoshimoto
Kazunori Hanada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2130185T3 publication Critical patent/ES2130185T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE PRESENTA UN FRAGMENTO DE DNA QUE TIENE LA SECUENCIA BASE REPRESENTADA POR LA FORMULA (I) Y QUE CODIFICA UN FACTOR DE INHIBICION DE PROLIFERACION DE CELULAS TUMORALES QUE PUEDE OBTENERSE PREPARANDO UNA BIBLIOTECA DE CDNA A PARTIR DEL MRNA DE UNA LINEA CELULAR ESTABLECIDA DERIVADA DE LAS CELULAS 3T3, AMPLIFICANDO DIFERENTES FRAGMENTOS DE DNA QUE SUPUESTAMENTE CODIFICAN EL FACTOR DE INHIBICION DE LA PROLIFERACION DE CELULAS TUMORALES MEDIANTE LA TECNICA DE PCR, Y ANALIZANDO LAS SECUENCIAS DE BASE DE LOS FRAGMENTOS DE DNA AMPLIFICADOS PARA DETERMINAR LA SECUENCIA DE BASE DEL DNA QUE CODIFICA EL FACTOR DE INHIBICION. EN DICHA FORMULA (I) X REPRESENTA TTC TTT CTA O TTC.
ES92924873T 1991-12-05 1992-12-03 Fragmento de adn codante para un factor de inhibicion de la proliferacion de celulas tumorales. Expired - Lifetime ES2130185T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32192991 1991-12-05

Publications (1)

Publication Number Publication Date
ES2130185T3 true ES2130185T3 (es) 1999-07-01

Family

ID=18137997

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92924873T Expired - Lifetime ES2130185T3 (es) 1991-12-05 1992-12-03 Fragmento de adn codante para un factor de inhibicion de la proliferacion de celulas tumorales.

Country Status (10)

Country Link
US (1) US5523391A (es)
EP (1) EP0617122B1 (es)
JP (1) JP2784264B2 (es)
KR (1) KR100239335B1 (es)
AT (1) ATE177146T1 (es)
AU (1) AU666689B2 (es)
CA (1) CA2124941C (es)
DE (1) DE69228559T2 (es)
ES (1) ES2130185T3 (es)
WO (1) WO1993011233A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0703242A1 (en) * 1993-06-04 1996-03-27 Taisho Pharmaceutical Co. Ltd Human-origin tumor cell proliferation inhibiting factor
US8294552B2 (en) * 2001-07-10 2012-10-23 Xatra Fund Mx, Llc Facial scan biometrics on a payment device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675285A (en) * 1984-09-19 1987-06-23 Genetics Institute, Inc. Method for identification and isolation of DNA encoding a desired protein
JP2784272B2 (ja) * 1990-06-06 1998-08-06 大正製薬株式会社 腫瘍細胞増殖阻害因子
US5281520A (en) * 1990-09-12 1994-01-25 Zymogenetics, Inc. Method for producing acyloxyacyl hydrolase

Also Published As

Publication number Publication date
ATE177146T1 (de) 1999-03-15
JP2784264B2 (ja) 1998-08-06
DE69228559D1 (de) 1999-04-08
DE69228559T2 (de) 1999-06-17
AU3094692A (en) 1993-06-28
AU666689B2 (en) 1996-02-22
EP0617122A4 (en) 1995-06-07
WO1993011233A1 (en) 1993-06-10
EP0617122B1 (en) 1999-03-03
EP0617122A1 (en) 1994-09-28
CA2124941A1 (en) 1993-06-10
KR100239335B1 (ko) 2000-01-15
CA2124941C (en) 2002-07-23
US5523391A (en) 1996-06-04

Similar Documents

Publication Publication Date Title
AR031640A1 (es) Amplificacion isotermica de acidos nucleicos en un soporte solido
CY1111002T1 (el) Συνθεσεις και μεθοδοι για ανοσοθεραπεια ειδικη για wt1
ATE535615T1 (de) Chemisch modifizierte nukleinsäuren und methode zur kopplung von nukleinsäuren an einen festen träger
ATE469911T1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
ATE355367T1 (de) Normalisierte nukleinsäurebibliotheken sowie herstellungsverfahren derselben
ES2104690T3 (es) Modificaciones de la expresion de genes endogenos con un elemento regulador por medio de recombinacion homologa.
ES2061643T3 (es) Factor inhibidor de la leucemia.
DE69943286D1 (de) Fluoreszierende proteine aus nicht-biolumineszenten arten der klasse anthozoa, gene die diese proteine kodieren und deren verwendungen
FI961886A0 (fi) Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit
DK1511845T3 (da) Immunstimulatoriske oligonukleotider og anvendelser deraf
ATE250671T1 (de) Verfahren mit einer hohen umsatzrate für das auffinden von sequenzen oder genetischen veränderungen in nukleinsäuren
CY1113512T1 (el) Διαταξη περιλαμβανουσα ενα ηλεκτροδιο με νανοεπικαλυψη για την παρασκευη ενος πολυ σταθερου υδατικου διαλυματος και μεθοδος παραγωγης αυτου του υδατικου διαλυματος
NO20051138L (no) Nye farmasoytiske formuleringer av modafinil
CO5590933A2 (es) Composicion y metodo para el tratamiento de la diabetes
ATE237338T1 (de) Allogene parakrine cytokine tumor impfstoffe
ES2130185T3 (es) Fragmento de adn codante para un factor de inhibicion de la proliferacion de celulas tumorales.
ATE353939T1 (de) Hochtemperaturstabilisierung von uv-systemen
ATE295882T1 (de) Eine methode zur in vitro molekularen evolution der proteinfunktion
DK0889969T3 (da) Rekombinante adenovirale til genterapi af humane tumorer
IT1209548B (it) Derivati di acido poliidrossibenzoico ad azione farmaceutica.
AR014528A1 (es) Adn que comprende una secuencia de nucleotidos que se puede traducir a una proteina con actividad de invertasa, proteina derivada del adn que tieneactividad de invertasa pero que carece de actividad beta-fructofuranosidasa; metodo para producir adn y dicho metodo donde el adn es producido por una
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
FR2529558B1 (fr) Compositions durcissables a base de polyesters
ES2078501T3 (es) Metodo para el tratamiento de la trombocitopenia y composiciones farmaceuticas utiles para el mismo.
ATE248914T1 (de) Allogenes vakzin und synthesemethode für selbiges

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 617122

Country of ref document: ES